GW Henssler & Associates’s Eli Lilly LLY Stock Holding History

GW Henssler & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	1,085 +202	+23%	+$206K	0.06%	111
2026 Q1	$812K	Hold	883	–	–	0.04%	119
2025 Q4	$949K	Sell	883 -35	-4%	-$33.5K	0.05%	113
2025 Q3	$700K	Buy	918 +10	+1%	+$7.44K	0.04%	117
2025 Q2	$708K	Sell	908 -75	-8%	-$58.3K	0.04%	115
2025 Q1	$812K	Sell	983 -64	-6%	-$53.3K	0.05%	99
2024 Q4	$928K	Hold	1,047	–	–	0.05%	93
2024 Q3	$928K	Buy	1,047 +16	+2%	+$14.4K	0.05%	94
2024 Q2	$933K	Buy	1,031 +25	+2%	+$20K	0.06%	91
2024 Q1	$783K	Buy	1,006 +72	+8%	+$51.2K	0.05%	96
2023 Q4	$544K	Buy	934 +215	+30%	+$125K	0.04%	101
2023 Q3	$386K	Buy	719 +32	+5%	+$16.5K	0.03%	110
2023 Q2	$322K	Sell	687 -23	-3%	-$9.65K	0.02%	138
2023 Q1	$244K	Buy	+710	New	+$239K	0.02%	196

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

GW Henssler & Associates's LLY Position: Q2 2026 in Review

GW Henssler & Associates increased its Eli Lilly (LLY) stake by 23% in Q2 2026, buying an estimated $206K and bringing the position to 1,085 shares worth $1.3M. The position accounts for 0.06% of the portfolio, ranked #111.

GW Henssler & Associates first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

GW Henssler & Associates held 1,085 shares of Eli Lilly worth $1.3M as of Q2 2026.
GW Henssler & Associates bought 202 Eli Lilly shares in Q2 2026, an estimated $206K.
Eli Lilly made up 0.06% of GW Henssler & Associates's portfolio in Q2 2026, its #111 holding.
GW Henssler & Associates first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.